Zachary Adams, MD
Sleep Medicine · Alpharetta
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 27
- 7 carriers
- Office
- 1
Offices
1 location · Fusion Sleep LLC · 10 clinicians in this group
Plans that list them
27 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Adams’s office at (678) 990-3962 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A167567 · Current
Licensed to practise in California · since 2020 · expires 2028-01-31 · St. Matthew?S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60894787Physician And Surgeon License · since 2018 · expires 2027-09-17ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$151,871
Medicare paid this office $151,871 for 582 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 318 | $50,938 | $106 |
| Sleep study in sleep lab | 60 | $29,844 | $497 |
| Short return visit (20+ min) | 247 | $20,412 | $75 |
| New patient visit (45+ min) | 101 | $12,285 | $122 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $11,674 | $614 |
See all 9 services
| Return visit (30+ min) | 318 | $50,938 | $106 |
| Sleep study in sleep lab | 60 | $29,844 | $497 |
| Short return visit (20+ min) | 247 | $20,412 | $75 |
| New patient visit (45+ min) | 101 | $12,285 | $122 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $11,674 | $614 |
| Sleep study including heart rate, breathing, and sleep time | 71 | $8,754 | $122 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 435 | $8,560 | $14 |
| Therapy procedure using a positive pressure ventilator | 118 | $7,455 | $53 |
| Sleep study including heart rate, breathing, airflow, and effort | 16 | $1,453 | $91 |
Who their Medicare patients are
582 Original Medicare patients in 2024. Average age 72 · Under 65 8% · 85 and older 5% · Women 44% · Also on Medicaid 20% · Health risk score 1.00. At or below the middle of the specialty; the typical sleep medicine clinician is at 1.21.
Conditions among them: High blood pressure 70% · Depression 25% · Diabetes 24% · Coronary heart disease 23% · Atrial fibrillation 19% · Chronic kidney disease 16% · Heart failure 14% · Cancer 14% · COPD 10% · Stroke 7% · Dementia 4%.
The office billed $395,020, Medicare allowed $203,357 and paid $151,871; for 1,798 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 582 | 1,798 | 72 | 1.00 | $395,020 | $151,871 |
| 2023 | 651 | 1,404 | 71 | 1.00 | $461,210 | $175,447 |
| 2022 | 610 | 1,323 | 71 | 0.98 | $402,750 | $152,737 |
| 2021 | 611 | 1,311 | 70 | 1.02 | $364,975 | $151,901 |
| 2020 | 355 | 607 | 70 | 1.16 | $164,150 | $66,397 |
| 2019 | 351 | 683 | 68 | 1.39 | $122,480 | $49,292 |
| 2018 | 835 | 1,367 | 70 | 1.12 | $479,798 | $173,536 |
| 2017 | 693 | 890 | 71 | 0.97 | $257,323 | $100,254 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 326 | $48,757 | $98 |
| Sleep study in sleep lab | 69 | $35,733 | $518 |
| New patient visit (45+ min) | 192 | $24,487 | $128 |
| Short return visit (20+ min) | 271 | $22,333 | $71 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 29 | $17,757 | $592 |
| Sleep study including heart rate, breathing, and sleep time | 75 | $11,129 | $139 |
| Therapy procedure using a positive pressure ventilator | 124 | $8,802 | $53 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 32 | $2,711 | $77 |
2022: 8 services
| Return visit (30+ min) | 307 | $46,261 | $102 |
| Sleep study in sleep lab | 50 | $31,571 | $631 |
| Short return visit (20+ min) | 254 | $21,279 | $69 |
| New patient visit (45+ min) | 165 | $20,418 | $124 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $10,705 | $595 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 98 | $8,928 | $80 |
| Therapy procedure using a positive pressure ventilator | 108 | $8,443 | $51 |
| Sleep study including heart rate, breathing, and sleep time | 21 | $3,161 | $151 |
2021: 7 services
| Return visit (30+ min) | 351 | $52,551 | $108 |
| Short return visit (20+ min) | 262 | $25,525 | $75 |
| Sleep study in sleep lab | 37 | $25,035 | $626 |
| New patient visit (45+ min) | 132 | $18,408 | $139 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 101 | $16,213 | $157 |
| Therapy procedure using a positive pressure ventilator | 123 | $6,507 | $39 |
| New patient visit (30+ min) | 24 | $1,575 | $66 |
2020: 7 services
| Return visit (30+ min) | 146 | $16,024 | $91 |
| Short return visit (20+ min) | 174 | $12,725 | $65 |
| Sleep study in sleep lab | 17 | $10,645 | $626 |
| New patient visit (45+ min) | 68 | $10,035 | $148 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 51 | $9,533 | $187 |
| New patient visit (30+ min) | 37 | $3,346 | $90 |
| Therapy procedure using a positive pressure ventilator | 48 | $2,177 | $40 |
2019: 7 services
| Short return visit (20+ min) | 250 | $21,130 | $58 |
| New patient visit (45+ min) | 58 | $7,069 | $122 |
| New patient visit (30+ min) | 86 | $6,778 | $79 |
| Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | 76 | $5,053 | $66 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 45 | $4,800 | $102 |
| Sleep study in sleep lab (6 years or older) | 34 | $3,141 | $92 |
| Return visit (30+ min) | 12 | $1,112 | $86 |
2018: 7 services
| Sleep study in sleep lab (6 years or older) | 114 | $55,106 | $483 |
| Return visit (30+ min) | 529 | $44,543 | $68 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 64 | $32,622 | $502 |
| New patient visit (45+ min) | 169 | $18,331 | $108 |
| Short return visit (20+ min) | 244 | $13,196 | $47 |
| Sleep study including heart rate, breathing, airflow, and effort | 66 | $8,608 | $128 |
| New patient visit (30+ min) | 16 | $1,030 | $64 |
2017: 6 services
| Return visit (30+ min) | 505 | $44,808 | $83 |
| Sleep study in sleep lab (6 years or older) | 35 | $17,076 | $488 |
| New patient visit (45+ min) | 103 | $12,914 | $125 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 24 | $12,300 | $513 |
| Short return visit (20+ min) | 134 | $7,643 | $55 |
| Sleep study including heart rate, breathing, airflow, and effort | 42 | $5,225 | $124 |
Medicaid work
$161,965 in 2024
Medicaid paid $161,965 for 1,174 billed services this clinician did in 2024, up to 80 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 82 | $58,771 |
| Return visit (30+ min) | 464 | $51,851 |
| New patient visit (45+ min) | 112 | $19,589 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 283 | $17,701 |
| Short return visit (20+ min) | 157 | $12,278 |
| Cont airway pressure device | 14 | $1,055 |
| Humidifier, heated, used with positive airway pressure device | 29 | $719 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 33 | $0 |
| 2024 | 1,174 | 8 | 80 | $161,965 |
| 2023 | 1,826 | 9 | 72 | $298,283 |
| 2022 | 1,198 | 6 | 65 | $166,852 |
| 2021 | 1,239 | 6 | 57 | $131,804 |
| 2020 | 709 | 7 | 54 | $68,560 |
| 2019 | 647 | 4 | 47 | $21,478 |
| 2018 | 129 | 3 | 16 | $3,487 |
See the largest Medicaid services in earlier years
2023
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 175 | $123,910 |
| Return visit (30+ min) | 626 | $70,876 |
| New patient visit (45+ min) | 309 | $47,458 |
| Short return visit (20+ min) | 313 | $24,599 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 351 | $20,879 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 12 | $7,736 |
| Sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (eg, by airflow or peripheral arterial tone), and sleep time | 15 | $1,600 |
| Cont airway pressure device | 12 | $904 |
| Humidifier, heated, used with positive airway pressure device | 13 | $322 |
2022
| Return visit (30+ min) | 470 | $51,104 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 62 | $45,864 |
| New patient visit (45+ min) | 250 | $40,526 |
| Short return visit (20+ min) | 228 | $17,102 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 129 | $7,135 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 59 | $5,121 |
2021
| Return visit (30+ min) | 422 | $40,217 |
| New patient visit (45+ min) | 191 | $29,153 |
| Short return visit (20+ min) | 372 | $27,727 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 30 | $21,151 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 198 | $11,373 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 26 | $2,183 |
2020
| New patient visit (45+ min) | 117 | $18,437 |
| Return visit (30+ min) | 207 | $18,344 |
| Short return visit (20+ min) | 216 | $13,014 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 14 | $9,426 |
| Continuous positive airway pressure ventilation (CPAP), initiation and management | 127 | $7,402 |
| New patient visit (30+ min) | 16 | $1,703 |
| Humidifier, heated, used with positive airway pressure device | 12 | $235 |
2019
| Short return visit (20+ min) | 356 | $9,320 |
| New patient visit (45+ min) | 93 | $5,468 |
| New patient visit (30+ min) | 120 | $4,839 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 78 | $1,851 |
2018
| Return visit (30+ min) | 93 | $3,103 |
| Short return visit (20+ min) | 17 | $241 |
| New patient visit (45+ min) | 19 | $144 |
Drugs they prescribed that Part D paid
$28,592
Pharmacies billed $28,592 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
521 generic and 50 brand-name prescriptions · $28,592 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 18 | $10,251 | $569 |
| Horizant | 12 | $5,931 | $494 |
| Gabapentin | 94 | $1,268 | $13 |
| Temazepam | 28 | $1,118 | $40 |
| Zolpidem | 204 | $1,115 | $5 |
See all 12 drugs
| Belsomra | 18 | $10,251 | $569 |
| Horizant | 12 | $5,931 | $494 |
| Gabapentin | 94 | $1,268 | $13 |
| Temazepam | 28 | $1,118 | $40 |
| Zolpidem | 204 | $1,115 | $5 |
| Eszopiclone | 31 | $665 | $21 |
| Zaleplon | 19 | $445 | $23 |
| Trazodone | 39 | $347 | $9 |
| Zolpidem Tartrate Er | 22 | $223 | $10 |
| Modafinil | 11 | $193 | $18 |
| Clonazepam | 27 | $147 | $5 |
| Lorazepam | 15 | $42 | $3 |
Year by year
| 2024 | 571 | 101 | None | 9% | $28,592 |
| 2023 | 562 | 90 | None | 9% | $29,064 |
| 2022 | 472 | 78 | None | 8% | $24,548 |
| 2021 | 412 | 87 | None | 9% | $83,428 |
| 2020 | 184 | 56 | None | 9% | $7,285 |
| 2019 | 148 | 47 | None | None | $10,991 |
| 2018 | 410 | 71 | 0% (0) | 12% | $150,475 |
| 2017 | 171 | 66 | 0% (0) | None | $64,734 |
| 2016 | 744 | 70 | None | None | $42,809 |
| 2015 | 829 | 71 | None | None | $42,016 |
| 2014 | 403 | 54 | None | None | $18,160 |
| 2013 | 90 | 21 | None | 17% | $2,645 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Neupro | 11 | $9,473 | $861 |
| Horizant | 11 | $5,573 | $507 |
| Zolpidem | 211 | $1,846 | $9 |
| Temazepam | 25 | $1,669 | $67 |
| Eszopiclone | 29 | $1,246 | $43 |
| Gabapentin | 67 | $794 | $12 |
| Zolpidem Tartrate Er | 23 | $778 | $34 |
| Trazodone | 27 | $519 | $19 |
| Armodafinil | 11 | $258 | $23 |
| Zaleplon | 12 | $248 | $21 |
| Pramipexole Dihydrochloride | 11 | $194 | $18 |
| Modafinil | 14 | $191 | $14 |
| Clonazepam | 35 | $165 | $5 |
| Fluticasone Propionate | 11 | $162 | $15 |
2022: 11 drugs
| Neupro | 12 | $9,743 | $812 |
| Zolpidem | 173 | $1,230 | $7 |
| Eszopiclone | 26 | $1,213 | $47 |
| Gabapentin | 58 | $1,083 | $19 |
| Trazodone | 35 | $494 | $14 |
| Temazepam | 20 | $456 | $23 |
| Clonazepam | 34 | $218 | $6 |
| Zolpidem Tartrate Er | 13 | $169 | $13 |
| Pramipexole Dihydrochloride | 18 | $128 | $7 |
| Doxepin | 12 | $105 | $9 |
| Quetiapine | 12 | $95 | $8 |
2021: 10 drugs
| Wakix | 11 | $62,044 | $5,640 |
| Modafinil | 16 | $6,330 | $396 |
| Belsomra | 11 | $4,484 | $408 |
| Zolpidem | 148 | $1,012 | $7 |
| Trazodone | 38 | $536 | $14 |
| Clonazepam | 37 | $529 | $14 |
| Gabapentin | 51 | $497 | $10 |
| Eszopiclone | 13 | $488 | $38 |
| Temazepam | 23 | $443 | $19 |
| Doxepin | 14 | $298 | $21 |
2020: 3 drugs
| Zolpidem | 76 | $572 | $8 |
| Gabapentin | 21 | $152 | $7 |
| Clonazepam | 13 | $95 | $7 |
2019: 4 drugs
| Dextroamphetamine-Amphetamine | 25 | $1,460 | $58 |
| Methylphenidate | 14 | $1,049 | $75 |
| Pramipexole Dihydrochloride | 20 | $219 | $11 |
| Zolpidem | 12 | $72 | $6 |
2018: 10 drugs
| Armodafinil | 28 | $3,746 | $134 |
| Methylphenidate Er | 16 | $3,084 | $193 |
| Modafinil | 14 | $2,128 | $152 |
| Zolpidem Tartrate Er | 32 | $1,964 | $61 |
| Methylphenidate | 37 | $1,858 | $50 |
| Dextroamphetamine-Amphetamine | 33 | $1,703 | $52 |
| Gabapentin | 40 | $938 | $23 |
| Pramipexole Dihydrochloride | 57 | $559 | $10 |
| Zolpidem | 43 | $307 | $7 |
| Clonazepam | 41 | $208 | $5 |
2017: 7 drugs
| Methylphenidate Er | 13 | $1,859 | $143 |
| Methylphenidate | 14 | $872 | $62 |
| Dextroamphetamine-Amphetamine | 15 | $798 | $53 |
| Gabapentin | 11 | $359 | $33 |
| Pramipexole Dihydrochloride | 16 | $275 | $17 |
| Zolpidem | 19 | $197 | $10 |
| Clonazepam | 14 | $80 | $6 |
2016: 23 drugs
| Advair Diskus | 17 | $6,180 | $364 |
| Benicar Hct | 13 | $2,189 | $168 |
| Proair Hfa | 21 | $1,133 | $54 |
| Chlorthalidone | 22 | $730 | $33 |
| Ventolin Hfa | 11 | $573 | $52 |
| Pravastatin | 29 | $398 | $14 |
| Amlodipine Besylate | 38 | $295 | $8 |
| Atorvastatin | 18 | $272 | $15 |
| Lisinopril | 43 | $267 | $6 |
| Metformin | 21 | $252 | $12 |
| Fluticasone Propionate | 30 | $249 | $8 |
| Levothyroxine | 25 | $226 | $9 |
| Metoprolol | 13 | $207 | $16 |
| Simvastatin | 23 | $198 | $9 |
| Potassium Chloride | 12 | $166 | $14 |
| Pantoprazole | 13 | $140 | $11 |
| Spironolactone | 15 | $122 | $8 |
| Glipizide | 14 | $109 | $8 |
| Hydrochlorothiazide | 11 | $81 | $7 |
| Warfarin | 16 | $77 | $5 |
| Omeprazole | 17 | $74 | $4 |
| Lisinopril-Hydrochlorothiazide | 19 | $62 | $3 |
| Furosemide | 11 | $24 | $2 |
2015: 23 drugs
| Proair Hfa | 39 | $2,047 | $52 |
| Chlorthalidone | 11 | $390 | $35 |
| Pravastatin | 32 | $354 | $11 |
| Metoprolol | 17 | $353 | $21 |
| Atorvastatin | 28 | $341 | $12 |
| Lisinopril | 53 | $332 | $6 |
| Amlodipine Besylate | 34 | $315 | $9 |
| Potassium Chloride | 18 | $287 | $16 |
| Gabapentin | 15 | $282 | $19 |
| Simvastatin | 38 | $235 | $6 |
| Fluticasone Propionate | 22 | $191 | $9 |
| Lisinopril-Hydrochlorothiazide | 17 | $117 | $7 |
| Levothyroxine | 11 | $116 | $11 |
| Omeprazole | 15 | $116 | $8 |
| Furosemide | 31 | $103 | $3 |
| Hydrochlorothiazide | 13 | $91 | $7 |
| Meloxicam | 16 | $83 | $5 |
| Pantoprazole | 11 | $80 | $7 |
| Meclizine | 11 | $74 | $7 |
| Naproxen | 15 | $69 | $5 |
| Metoprolol | 13 | $65 | $5 |
| Metformin | 16 | $61 | $4 |
| Benazepril | 11 | $61 | $6 |
2014: 14 drugs
| Metoprolol | 11 | $546 | $50 |
| Pravastatin | 21 | $417 | $20 |
| Potassium Chloride | 13 | $271 | $21 |
| Hydralazine | 12 | $258 | $22 |
| Fluticasone Propionate | 13 | $207 | $16 |
| Amlodipine Besylate | 19 | $197 | $10 |
| Levothyroxine | 13 | $152 | $12 |
| Atorvastatin | 12 | $148 | $12 |
| Lisinopril-Hydrochlorothiazide | 17 | $113 | $7 |
| Metformin | 12 | $94 | $8 |
| Meloxicam | 13 | $84 | $6 |
| Lisinopril | 12 | $75 | $6 |
| Furosemide | 14 | $38 | $3 |
| Hydrochlorothiazide | 11 | $36 | $3 |
Money from drug and device companies
$139 in 2025
| 2025 | 3 | 3 | None | $139 |
| 2023 | 5 | 9 | None | $225 |
| 2022 | 4 | 8 | None | $264 |
| 2021 | 2 | 5 | None | $127 |
| 2020 | 2 | 5 | None | $127 |
| 2019 | 12 | 39 | None | $528 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $60 | 1 payment
|
| Itamar Medical | Watchpatone | $55 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $24 | 1 payment
|
See all 3 published payments
| Inspire Medical Systems | Meals · 2025-09-25 | Inspire | $60 |
| Idorsia Pharmaceuticals US | Meals · 2025-06-24 | Quviviq | $24 |
| Itamar Medical | Meals · 2025-03-12 | Watchpatone | $55 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $225
| Harmony Biosciences | Wakix | $115 | 3 payments
|
| Inspire Medical Systems | Inspire | $59 | 3 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $20 | 1 payment
|
| Itamar Medical | Watchpatone | $16 | 1 payment
|
| Axsome Therapeutics | Sunosi | $15 | 1 payment
|
2022: $264
| Harmony Biosciences | Wakix | $205 | 5 payments
|
| Jazz Pharmaceuticals | Xywav | $26 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $20 | 1 payment
|
| Itamar Medical | Watchpat | $14 | 1 payment
|
2021: $127
| Jazz Pharmaceuticals | Xywav | $88 | 4 payments
|
| Harmony Biosciences | Wakix | $39 | 1 payment
|
2020: $127
| Harmony Biosciences | Wakix | $105 | 4 payments
|
| Jazz Pharmaceuticals | Xywav | $22 | 1 payment
|
2019: $528
| GlaxoSmithKline | Anoro | $124 | 18 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $107 | 5 payments
|
| Philips Electronics North America | Incourage | $51 | 2 payments
|
| United Therapeutics | Orenitram | $46 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $44 | 3 payments
|
| Insmed | Arikayce | $36 | 2 payments
|
| Jazz Pharmaceuticals | Xyrem | $35 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $21 | 1 payment
|
| Circassia Pharmaceuticals | Tudorza Pressair | $19 | 1 payment
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $16 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $15 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $14 | 1 payment
|
Checkups this office reported
13 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 74.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 0%That's few of the people this applied to. | 716 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 5%That's few of the people this applied to. | 1,302 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 22%That's few of the people this applied to. | 343 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 684 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 23% | 253 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 2,034 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 100%That's most of the people this applied to. Worse on this measure. | 103 |
| Medications listed in the chartVisits where the current medication list was documented | 90%That's most of the people this applied to. | 3,717 |
See the other 5 measures
| Patients can see their records onlinePatients who were given electronic access to their health information | 90%That's most of the people this applied to. | 895 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 1%That's few of the people this applied to. Better on this measure. | 732 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 14% | 352 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 71%That's more than half. | 126 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 15%That's few of the people this applied to. | 295 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Tobacco use
- Uses standard treatment protocols
- Exempt from e-prescribing
- Exempt from immunization registry reporting
Professional record
- NPI
- 1073956231
- Licence
- CA A167567, WA 60894787California A167567: Current · expires 2028-01-31Washington MD.MD.60894787: Active
- Group
- Fusion Sleep LLC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS1201X (207QS1201X)
- Mailing address
- 100 Kimball Pl Ste 100, Alpharetta, GA, 30009
- NPI first listed
- 2013-04-08
- NPI last updated
- 2026-02-19
- NPI record certified
- 2026-02-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3650 Mansell Rd Ste 125, Alpharetta, GA, 30022 · 150 Carnation Dr Ste 4, Freedom, CA, 95019 · 777 Knowles Dr Ste 15, Los Gatos, CA, 95032 · 755 Arnold Way, Menlo Park, CA, 94025 · 101 Wilson Rd Ste D, Monterey, CA, 93940 · 1665 Dominican Way Ste 222, Santa Cruz, CA, 95065 · 260 S Sunnyvale Ave Ste 6, Sunnyvale, CA, 94086